Literature DB >> 33962913

Where are we with drug treatments for covid-19?

Chris Baraniuk1.   

Abstract

Entities:  

Year:  2021        PMID： 33962913     DOI： 10.1136/bmj.n1109

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Predicting the Effects of Waning Vaccine Immunity Against COVID-19 through High-Resolution Agent-Based Modeling.

Authors:  Agnieszka Truszkowska; Lorenzo Zino; Sachit Butail; Emanuele Caroppo; Zhong-Ping Jiang; Alessandro Rizzo; Maurizio Porfiri
Journal:  Adv Theory Simul       Date:  2022-02-14

2.  Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study.

Authors:  Young Rock Jang; Yoon Ju Oh; Jin Yong Kim
Journal:  Curr Ther Res Clin Exp       Date:  2022-05-16

3.  Debate on mandatory COVID-19 vaccination.

Authors:  F K Cheng
Journal:  Ethics Med Public Health       Date:  2022-01-24

Review 4.  Approved HIV reverse transcriptase inhibitors in the past decade.

Authors:  Guangdi Li; Yali Wang; Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2021-11-16       Impact factor: 14.903

5.  Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada.

Authors:  Sylvia H Hsu; Su-Hsin Chang; Cary P Gross; Shi-Yi Wang
Journal:  Int J Infect Dis       Date:  2021-07-01       Impact factor: 3.623
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.